Streetbeat News

Revenues

SLNH

Soluna Holdings, Inc. has secured an 8.8 MW hosting contract with an undisclosed Bitcoin miner. The company will host S19 and S19 Pro mining rigs under a 1-year profit-sharing arrangement. Soluna is currently preparing the site for the customer's hardware, which will be phased in over the coming weeks.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:47 pm

AISP

BYTS

Airship AI Holdings, Inc. (AISP) issued a stockholder letter reflecting on 2023 achievements, including a Nasdaq listing through a merger with BYTE Acquisition Corp. (BYTS). The company anticipates triple-digit revenue growth and positive EBITDA in 2024, backed by a $11.8M backlog and a $140M pipeline. Demand from Fortune 500 and government agencies, especially for border protection technologies, is driving growth. Investments in internal capabilities and new product launches, such as the Outpost AI edge appliance, are expected to capitalize on the $7.0 billion edge AI market.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:46 pm

BDRX

SNY

Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) CEO Stephen Stamp released a shareholder letter detailing the company's progress in 2023 and outlining expected milestones for 2024. Biodexa, which focuses on treatments for diseases with unmet medical needs, including Type 1 diabetes and rare brain cancers, has transitioned from a single-asset company to a multi-asset therapeutics company. Key developments include the in-licensing of tolimidone for Type 1 diabetes, advancement of MTX110 for Glioblastoma Multiforme, and progress on MTD217 for leptomeningeal disease. The company expects to announce various preclinical and clinical data in 2024 and has raised $6.0 million to support these efforts.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:45 pm

SDA

SunCar Technology Group Inc. has secured an exclusive vehicle service contract worth $3.5 million with the Sichuan branch of China Construction Bank. The contract is expected to enhance SunCar's revenue stream and solidify its presence in the Chinese market.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:37 pm

GNS

Genius Group forecasts a significant increase in revenue for 2024, projecting $58M-$60M, which represents a 110% year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:32 pm

AMD

ASML

BABA

BIDU

NVDA

TCEHY

China's imports of chipmaking machinery surged by 14% in 2023, reaching nearly $40 billion, in an effort to counter U.S. export controls and boost its semiconductor industry. Nvidia Corp (NVDA) dominates China's AI chip market, but U.S. sanctions and Chinese efforts to develop a domestic chip ecosystem are challenging its position. China's $40 billion state fund aims to support local chip manufacturing, while companies like Baidu (BIDU) and Alibaba (BABA) may reduce Nvidia chip orders. ASML Holding (ASML) halted shipments of high-end machines to China, and Advanced Micro Devices (AMD) is also affected by the embargo.

Portfolio Pulse from Anusuya Lahiri

January 22, 2024 | 1:23 pm

ADNT

Adient, an automotive seating company, has reported preliminary revenue for Q1 2024 at approximately $3.7 billion, which is slightly below the estimated $3.72 billion.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:22 pm

BOF

BranchOut Food Inc. (NASDAQ:BOF) reported preliminary Q4 2023 revenue of approximately $1.6 million, a 43% increase over Q3 2023, and an 80% increase over the full year 2022 revenue. The company's annual run rate is now around $6.4 million. CEO Eric Healy highlighted the company's strong performance, new customer acquisitions, and positive outlook for continued revenue growth and gross margin improvement in 2024.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:21 pm

ARQT

Arcutis Biotherapeutics, Inc. has launched ZORYVE topical foam for the treatment of seborrheic dermatitis in the U.S. ZORYVE is the first drug with a new mechanism of action for this condition in over 20 years and is available in pharmacies with strong reimbursement from major pharmacy benefit managers. The product is steroid-free, offers rapid disease clearance, and is well-tolerated. Arcutis will host a conference call to discuss the launch and has programs to support patient access and adherence.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:17 pm

VTAK

Catheter Precision, Inc. (NYSE:VTAK), a US-based medical device company, has signed a distribution agreement with Supri Artigos Medico Hospitalares Ltda for its electrophysiology product, LockeT, in Brazil. This marks the company's first distributor in South America, aiming to provide innovative technologies to improve patient care and workflow efficiency in a cost-effective manner.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:09 pm